TY  - GEN
AU  - Feldmann,Georg
AU  - Mishra,Anjali
AU  - Bisht,Savita
AU  - Karikari,Collins
AU  - Garrido-Laguna,Ignacio
AU  - Rasheed,Zeshaan
AU  - Ottenhof,Niki A
AU  - Dadon,Tikva
AU  - Alvarez,Hector
AU  - Fendrich,Volker
AU  - Rajeshkumar,N V
AU  - Matsui,William
AU  - Brossart,Peter
AU  - Hidalgo,Manuel
AU  - Bannerji,Rajat
AU  - Maitra,Anirban
AU  - Nelkin,Barry D
TI  - Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models
SN  - 1555-8576
PY  - 2012///0328
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Bridged Bicyclo Compounds, Heterocyclic
KW  - administration & dosage
KW  - Cell Line, Tumor
KW  - Cell Movement
KW  - drug effects
KW  - Cell Proliferation
KW  - Cyclic N-Oxides
KW  - Cyclin-Dependent Kinases
KW  - antagonists & inhibitors
KW  - Deoxycytidine
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Enzyme Inhibitors
KW  - Humans
KW  - Indolizines
KW  - Male
KW  - Mice
KW  - Mice, Nude
KW  - Pancreatic Neoplasms
KW  - drug therapy
KW  - Phosphorylation
KW  - Pyridinium Compounds
KW  - Receptors, Notch
KW  - Retinoblastoma Protein
KW  - metabolism
KW  - Signal Transduction
KW  - Transforming Growth Factor beta
KW  - Xenograft Model Antitumor Assays
KW  - ral GTP-Binding Proteins
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.4161/cbt.12.7.16475
ER  -